Ken Kato

Ken Kato is a medical oncologist and chief of Department of Head and Neck, and Esophageal Medical Oncology, and Gastrointestinal Medical Oncology, National Cancer Center Hospital, 2020-2022, and chief, Biobank Translational Research Support Section, Clinical Research Coordinating Section, Clinical Research Support Office, National Cancer Center Hospital.

Ken Katos primary interest is chemotherapy and chemoradiotherapy for oesophageal, esophagogastric, and gastric cancer. Ken Kato is a group coordinator of the Japan Esophageal Oncology Group of JCOG, the most significant clinical trial group for cancer in Japan.